home / stock / tela / tela news

TELA News and Press, TELA Bio Inc. From 10/27/21

Stock Information
Company Name: TELA Bio Inc.
Stock Symbol: TELA
Market: NYSE
Website: telabio.com
Menu
TELA TELA Quote TELA Short TELA News TELA Articles TELA Message Board
Get TELA Alerts

News, Short Squeeze, Breakout and More Instantly...
TELA - TELA Bio to Announce Third Quarter 2021 Financial Results

MALVERN, Pa., Oct. 27, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the com...
TELA - TELA Bio Plugging Away

TELA Bio sells OviTex for hernia repair ($1.5B TAM) and plastic surgery ($500M TAM), a reinforced mesh made of embroidered sheep stomach that is 95% biologic + 5% synthetic. Clinical evidence continues to show positive results, while mesh incumbents Becton, Dickinson (BDX) and J&J...

TELA - TELA Bio® Announces New Data on Use of OviTex in a Range of Hernia Repair Applications, Including Novel ReBAR (Reinforced Biologic Augmented Repair) Technique

MALVERN, Pa., Sept. 13, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced ...

TELA - TELA Bio's OviTex® Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021

MALVERN, Pa., Aug. 16, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announc...
TELA - TELA Bio, Inc. (TELA) Q2 2021 Earnings Call Transcript

Image source: The Motley Fool. TELA Bio, Inc. (NASDAQ: TELA) Q2 2021 Earnings Call Aug 11, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: TELA Bio, Inc. (TELA) Q2 2021 Earnings Call Transcript

TELA - TELA Bio's (TELA) CEO Tony Koblish on Q2 2021 Results - Earnings Call Transcript

TELA Bio, Inc. (TELA) Q2 2021 Earnings Conference Call August 11, 2021 4:30 PM ET Company Participants Greg Chodaczek – Investor Relations Tony Koblish – President and Chief Executive Officer Megan Smeykal – Vice President and Corporate Controller Conference Call Particip...

TELA - TELA Bio Reports Record Second Quarter 2021 Revenues Driven by Increased Demand

MALVERN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today reporte...
TELA - TELA Bio to Participate in Canaccord Genuity's 41st Annual Growth Conference

MALVERN, Pa., Aug. 03, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Com...

TELA - TELA Bio to Announce Second Quarter 2021 Financial Results

MALVERN, Pa., July 28, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the com...

TELA - NHS Surgeon First in Europe to Implant TELA Bio's OviTex® LPR Reinforced Tissue Matrix

MALVERN, Pa., July 21, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced today the fi...
Previous 10 Next 10